Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Human Stem Cells Institute financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Revenue

₽1.7 B

FY, 2025

CreditSafe Score

?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

RUBFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue643.5M835.1M1.1B1.2B1.1B1.4B1.5B1.7B
Cost of goods sold72.9M153.2M297.8M283.4M252.3M287.1M292.9M330.8M
Gross profit571.8M682.4M786.3M897.4M884.6M1.1B1.2B1.4B
Gross profit margin, %88.9%81.7%73.5%76.6%79.5%79.9%81.4%81.1%
Operating expense total392.2M451.4M516.5M706.8M731.9M735.7M844.2M1.1B
Depreciation and amortization50.8M60.0M74.9M81.3M53.5M70.9M88.7M142.1M
EBITDA179.7M230.9M269.4M185.4M175.8M321.6M380.8M251.0M
EBITDA margin, %27.9%27.7%25.2%15.8%15.8%23.8%25.2%14.7%
EBIT(25.6M)126.3M36.1M92.1M128.0M229.2M239.9M106.6M
EBIT margin, %-4.0%15.1%3.4%7.9%11.5%16.9%15.9%6.2%
Interest income3.3M4.9M4.0M6.2M12.5M32.3M75.4M102.4M
Interest expense30.2M41.5M40.2M50.7M81.1M62.2M757.0M391.5M
Pre tax profit(53.8M)101.4M93.5M29.5M29.3M211.4M217.4M85.5M
Income tax expense(35.6M)(9.9M)(9.9M)(4.1M)6.2M16.7M(23.7M)(22.2M)
Net Income(18.2M)111.3M103.4M33.5M23.1M194.7M241.2M107.7M

Footer menu